Baseline pulmonary function and quality of life 9 years later in a middle-aged Chinese population

Chest

Volumn 128, Issue 4, 2005, Pages 2448-2457

  Xie, Gaoqiang ^a   Li, Ying ^a   Shi, Ping ^b   Zhou, Beifan ^a   Zhang, Puhong ^a   Wu, Yangfeng ^a  

^a FUWAI HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Chinese; Prospective study; Pulmonary function; Quality of life

Indexed keywords

ADULT; ARTICLE; ASTHMA; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; COUGHING; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; SCORING SYSTEM; SYMPTOMATOLOGY;

EID: 27144460815     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.4.2448     Document Type: Article

References (26)

1. Fayers PM, Machin D. Quality of life: assessment, analysis and interpretation. 1st ed. Chichester, NY: Wiley & Sons, 2000; 1-27
2. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:680-685
3. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO global initiative for chronic obstructive pulmonary disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
4. Wijnhoven HAH, Kriegsman DMW, Hesselink AE, et al. Determinants of different dimensions of disease severity in asthma and COPD: pulmonary function and health-related quality of life. Chest 2001; 119:1034-1042
5. De JW, Kaptein AA, Van DSCP, et al. Quality of life in patients with cystic fibrosis. Pediatr Pulmonol 1997; 23:95-100
6. Engström CP, Persson LO, Larsson S, et al. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Thorax 1996; 51:825-830
7. Kaptein AA, Brand PLP, Dekker FW, et al. Quality of life in a long-term multicentre trial in chronic nonspecific lung disease: assessment at baseline. Eur Respir J 1993; 6:1479-1484
8. Cox CE, Donohue JF, Brown CD, et al. Health-related quality of life of persons with sarcoidosis. Chest 2004; 125: 997-1004
9. Monso E, Fiz JM, Izquierdo J, et al. Quality of life in severe chronic obstructive pulmonary disease: correlation with lung and muscle function. Respir Med 1998; 92:221-227
10. Prigatano GP, Wright EC, Levin D. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med 1984; 144: 1613-1619
11. Schrier AC, Dekker FW, Kaptein AA, et al. Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice. Chest 1990; 98:894-899
12. Hajiro T, Nishimura K, Tsulkino M, et al. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:785-790
13. Boueri FM, Bucher-Bartelson BL, Glenn KA, et al. Quality of life measured with a generic instrument (Short Form-36) improves following pulmonary rehabilitation in patients with COPD. Chest 2001; 119:77-84
14. Spencer S, Calverley PMA, Burge PS, et al. Health status deterioration in patients with chronic with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 122-128
15. 1) and the ADAPT quality-of-life scale. Percept Mot Skills 1983; 57:359-362
16. Yang G, Fan L, Tan J, et al. Smoking in China: finding of the 1996 National Prevalence Survey. JAMA 1999; 282:1247-1253
17. People's Republic of China-United States Cardiovascular and Cadiopulmonary Epidemiology Research Group. An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China: baseline report from the P.R.C.-U.S.A. Collaborative Study. Circulation 1992; 85:1083-1096
18. Vollmer WM, Tsai R, Wu Y, et al. Pattern of pulmonary function in asymptomatic nonsmoking men and women in the People's Republic of China. Ann Epidemiol 2002; 12:295-302
19. Rao X, Cai R, Huang Z, et al. Effects of smoking on pulmonary function in populations of Beijing and Guangzhou. Zhonghua Jie He He Hu Xi Za Zhi 1996; 19:14-17
20. American Thoracic Society. Standardization of spirometry, 1987 update. Am Rev Respir Dis 1987; 136:1285-1298
21. Osborne ML, Vollmer WM, Linton KL, et al. Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med 1998; 157:123-128
22. Rahman I, MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996; 51:348-350
23. 1: the Lung Health Study. JAMA 1994; 272:1497-1505
24. Robert P. The future of global ageing. Int J Epidemiol 2002; 31:786-791
25. Boom GVD, Mölken MPMHR, Molema J, et al. The cost effectiveness of early treatment with fluticasone propionate 250 ?g twice a day in subjects with obstructive airway disease, results of the DIMCA program. Am J Respir Crit Care Med 2001; 164:2057-2066
26. Grunsven PV, Schermer T, Akkermans R, et al. Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease: results of the DIMCA study. Respir Med 2003; 97:1303-1312